世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global COVID-19 RNA Vaccine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1626 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：New Technology

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、新型コロナウイルス感染症RNAワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症RNAワクチンの市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症RNAワクチンの種類別市場規模（開発中、前臨床、臨床I、臨床II） ・新型コロナウイルス感染症RNAワクチンの用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他） ・新型コロナウイルス感染症RNAワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症RNAワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症RNAワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症RNAワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症RNAワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（MODERNA、CureVac、Zydus Cadila、BioNTech、Stermirna） ・結論

RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, usually wrapped in lipid nanoparticles.They fuse with cells.Once inside the cell, the RNA sequence is translated by the ribosome into a protein or part of a protein.

In 2021, the global COVID-19 RNA Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 RNA Vaccine status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 RNA Vaccine development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global COVID-19 RNA Vaccine Scope and Market Size
COVID-19 RNA Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 RNA Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Being Developed
Preclinical
Clinical I
Clinical II

Segment by Application
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
MODERNA
CureVac
Zydus Cadila
BioNTech

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 RNA Vaccine Market Size Growth Rate by Type (2021-2027)
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global COVID-19 RNA Vaccine Market Share by Application (2021-2027)
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global COVID-19 RNA Vaccine Market Size
2.2 COVID-19 RNA Vaccine Market Size by Regions
2.2.1 COVID-19 RNA Vaccine Growth Rate by Regions (2021-2027)
2.2.2 COVID-19 RNA Vaccine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 COVID-19 RNA Vaccine Revenue by Players (2020-2021)
3.2 COVID-19 RNA Vaccine Key Players Headquaters and Area Served
3.3 Key Players COVID-19 RNA Vaccine Product/Solution/Service
3.4 Date of Enter into COVID-19 RNA Vaccine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global COVID-19 RNA Vaccine Market Size by Type (2021-2027)
4.2 Global COVID-19 RNA Vaccine Market Size by Application (2021-2027)

5 North America
5.1 North America COVID-19 RNA Vaccine Market Forecast (2021-2027)
5.2 COVID-19 RNA Vaccine Key Players in North America
5.3 North America COVID-19 RNA Vaccine Market Size by Type
5.4 North America COVID-19 RNA Vaccine Market Size by Application

6 Europe
6.1 Europe COVID-19 RNA Vaccine Market Forecast (2021-2027)
6.2 COVID-19 RNA Vaccine Key Players in Europe
6.3 Europe COVID-19 RNA Vaccine Market Size by Type
6.4 Europe COVID-19 RNA Vaccine Market Size by Application

7 Japan
7.1 Japan COVID-19 RNA Vaccine Market Forecast (2021-2027)
7.2 COVID-19 RNA Vaccine Key Players in Europe
7.3 Japan COVID-19 RNA Vaccine Market Size by Type
7.4 Japan COVID-19 RNA Vaccine Market Size by Application

8 Rest of World
8.1 China
8.1.1 China COVID-19 RNA Vaccine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia COVID-19 RNA Vaccine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India COVID-19 RNA Vaccine Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 MODERNA
9.1.1 MODERNA Company Details
9.1.2 MODERNA Description and Business Overview
9.1.3 MODERNA COVID-19 RNA Vaccine Introduction
9.1.4 MODERNA Revenue in COVID-19 RNA Vaccine Business (2020-2021)
9.1.5 MODERNA Recent Development
9.2 CureVac
9.2.1 CureVac Company Details
9.2.2 CureVac Description and Business Overview
9.2.3 CureVac COVID-19 RNA Vaccine Introduction
9.2.4 CureVac Revenue in COVID-19 RNA Vaccine Business (2020-2021)
9.2.5 CureVac Recent Development
9.3 Zydus Cadila
9.3.1 Zydus Cadila Company Details
9.3.2 Zydus Cadila Description and Business Overview
9.3.3 Zydus Cadila COVID-19 RNA Vaccine Introduction
9.3.4 Zydus Cadila Revenue in COVID-19 RNA Vaccine Business (2020-2021)
9.3.5 Zydus Cadila Recent Development
9.4 BioNTech
9.4.1 BioNTech Company Details
9.4.2 BioNTech Description and Business Overview
9.4.3 BioNTech COVID-19 RNA Vaccine Introduction
9.4.4 BioNTech Revenue in COVID-19 RNA Vaccine Business (2020-2021)
9.4.5 BioNTech Recent Development
9.5 Stermirna
9.5.1 Stermirna Company Details
9.5.2 Stermirna Description and Business Overview
9.5.3 Stermirna COVID-19 RNA Vaccine Introduction
9.5.4 Stermirna Revenue in COVID-19 RNA Vaccine Business (2020-2021)
9.5.5 Stermirna Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global COVID-19 RNA Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Being Developed
Table 3. Key Players of Preclinical
Table 4. Key Players of Clinical I
Table 5. Key Players of Clinical II
Table 6. Global COVID-19 RNA Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global COVID-19 RNA Vaccine Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global COVID-19 RNA Vaccine Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global COVID-19 RNA Vaccine Revenue by Players (2020-2021) (US$ Million)
Table 12. Global COVID-19 RNA Vaccine Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players COVID-19 RNA Vaccine Product Solution and Service
Table 15. Date of Enter into COVID-19 RNA Vaccine Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global COVID-19 RNA Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 18. Global COVID-19 RNA Vaccine Market Size Share by Type (2021-2027)
Table 19. Global COVID-19 RNA Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 20. Global COVID-19 RNA Vaccine Market Size Share by Application (2021-2027)
Table 21. North America Key Players COVID-19 RNA Vaccine Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players COVID-19 RNA Vaccine Market Share (2020-2021)
Table 23. North America COVID-19 RNA Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 24. North America COVID-19 RNA Vaccine Market Share by Type (2021-2027)
Table 25. North America COVID-19 RNA Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 26. North America COVID-19 RNA Vaccine Market Share by Application (2021-2027)
Table 27. Europe Key Players COVID-19 RNA Vaccine Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players COVID-19 RNA Vaccine Market Share (2020-2021)
Table 29. Europe COVID-19 RNA Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe COVID-19 RNA Vaccine Market Share by Type (2021-2027)
Table 31. Europe COVID-19 RNA Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe COVID-19 RNA Vaccine Market Share by Application (2021-2027)
Table 33. Japan Key Players COVID-19 RNA Vaccine Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players COVID-19 RNA Vaccine Market Share (2020-2021)
Table 35. Japan COVID-19 RNA Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan COVID-19 RNA Vaccine Market Share by Type (2021-2027)
Table 37. Japan COVID-19 RNA Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan COVID-19 RNA Vaccine Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. MODERNA Company Details
Table 43. MODERNA Description and Business Overview
Table 44. MODERNA COVID-19 RNA Vaccine Product
Table 45. MODERNA Revenue in COVID-19 RNA Vaccine Business 2020 and 2021
Table 46. MODERNA Recent Development
Table 47. CureVac Company Details
Table 48. CureVac Description and Business Overview
Table 49. CureVac COVID-19 RNA Vaccine Product
Table 50. CureVac Revenue in COVID-19 RNA Vaccine Business 2020 and 2021
Table 51. CureVac Recent Development
Table 52. Zydus Cadila Company Details
Table 53. Zydus Cadila Description and Business Overview
Table 54. Zydus Cadila COVID-19 RNA Vaccine Product
Table 55. Zydus Cadila Revenue in COVID-19 RNA Vaccine Business 2020 and 2021
Table 56. Zydus Cadila Recent Development
Table 57. BioNTech Company Details
Table 58. BioNTech Description and Business Overview
Table 59. BioNTech COVID-19 RNA Vaccine Product
Table 60. BioNTech Revenue in COVID-19 RNA Vaccine Business 2020 and 2021
Table 61. BioNTech Recent Development
Table 62. Stermirna Company Details
Table 63. Stermirna Description and Business Overview
Table 64. Stermirna COVID-19 RNA Vaccine Product
Table 65. Stermirna Revenue in COVID-19 RNA Vaccine Business 2020 and 2021
Table 66. Stermirna Recent Development
Table 67. COVID-19 RNA Vaccine Market Trends
Table 68. COVID-19 RNA Vaccine Market Drivers
Table 69. COVID-19 RNA Vaccine Market Challenges
Table 70. COVID-19 RNA Vaccine Market Restraints
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 RNA Vaccine Market Share by Type in 2021 & 2027
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global COVID-19 RNA Vaccine Market Share by Application in 2021 & 2027
Figure 7. Pharmaceutical And Biotechnology Companies Case Studies
Figure 8. Hospital Case Studies
Figure 9. Academic And Research Organizations Case Studies
Figure 10. Other Case Studies
Figure 11. COVID-19 RNA Vaccine Report Years Considered
Figure 12. Global COVID-19 RNA Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 13. Global COVID-19 RNA Vaccine Market Share by Regions (2020-2027)
Figure 14. Global COVID-19 RNA Vaccine Market Share by Players in 2021
Figure 15. Global COVID-19 RNA Vaccine Market Size Market Share by Type (2021-2027)
Figure 16. Global COVID-19 RNA Vaccine Market Size Market Share by Application (2021-2027)
Figure 17. Global COVID-19 RNA Vaccine Revenue Market Share by Application in 2021
Figure 18. North America COVID-19 RNA Vaccine Market Size 2021-2027 (US$ Million)
Figure 19. Europe COVID-19 RNA Vaccine Market Size 2021-2027 (US$ Million)
Figure 20. Japan COVID-19 RNA Vaccine Market Size 2021-2027 (US$ Million)
Figure 21. COVID-19 RNA Vaccine Market Size in China (2021-2027) (US$ Million)
Figure 22. COVID-19 RNA Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 23. COVID-19 RNA Vaccine Market Size in India (2021-2027) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---